Murine and human hematopoietic progenitor cultures grown on stromal layers expressing Notch ligands
- Авторлар: Raevskaya A.A.1, Savvateeva M.V.1, Bukhinnik S.S.1, Kandarakov O.F.1, Butylin P.A.2, Zhuk S.V.2, Demin A.M.3, Krasnov V.P.3, Zaritsky A.Y.2, Belyavsky A.V.1
-
Мекемелер:
- Engelhardt Institute of Molecular Biology
- Almazov Federal North-West Medical Research Center
- Postovsky Institute of Organic Synthesis
- Шығарылым: Том 51, № 2 (2017)
- Беттер: 313-322
- Бөлім: Molecular Cell Biology
- URL: https://journals.rcsi.science/0026-8933/article/view/163044
- DOI: https://doi.org/10.1134/S0026893317020169
- ID: 163044
Дәйексөз келтіру
Аннотация
The ex vivo maintenance and expansion of hematopoietic stem cells and early progenitors is necessary for the successful treatment of hematopoietic and immune diseases. Multiple attempts to improve the expansion of hematopoietic stem cells (HSCs) by their cultivation in the presence of growth factor cocktails have so far failed. Novel approaches aimed at conserving the earliest precursors in their undifferentiated state are needed. These approaches should take into account local regulatory factors that are present in the HSC microenvironment and the three-dimensional architecture of their niche. In the present study, we compared the effects of two Notch ligands, i.e., Jagged1 and DLL1, on murine and human hematopoiesis in vitro. Our observations indicate that the stromal expression of Notch ligands increases the production of both the total and phenotypically early murine and human hematopoietic cells in the co-culture. On one hand, this study demonstrates the similarity of effects of stromal expression of Notch ligands on murine and human hematopoiesis in vitro. On the other hand, our study revealed a number of cell type and ligand-specific variations that are systematically described below. It seems that the effects of SCF cytokine addition on murine hematopoiesis in vitro depend on the stromal context and are oppositely directed for Jagged1 and DLL1.
Негізгі сөздер
Авторлар туралы
A. Raevskaya
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Ресей, Moscow, 119991
M. Savvateeva
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Ресей, Moscow, 119991
S. Bukhinnik
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Ресей, Moscow, 119991
O. Kandarakov
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Ресей, Moscow, 119991
P. Butylin
Almazov Federal North-West Medical Research Center
Email: abelyavs@yahoo.com
Ресей, St. Petersburg, 197341
S. Zhuk
Almazov Federal North-West Medical Research Center
Email: abelyavs@yahoo.com
Ресей, St. Petersburg, 197341
A. Demin
Postovsky Institute of Organic Synthesis
Email: abelyavs@yahoo.com
Ресей, Yekaterinburg, 620990
V. Krasnov
Postovsky Institute of Organic Synthesis
Email: abelyavs@yahoo.com
Ресей, Yekaterinburg, 620990
A. Zaritsky
Almazov Federal North-West Medical Research Center
Email: abelyavs@yahoo.com
Ресей, St. Petersburg, 197341
A. Belyavsky
Engelhardt Institute of Molecular Biology
Хат алмасуға жауапты Автор.
Email: abelyavs@yahoo.com
Ресей, Moscow, 119991
Қосымша файлдар
